Siim Land: What the Most Promising Longevity Drug Did for Humans – Dr. Brad Stanfield
Peer-Reviewed Research
Key Takeaways
- Rapamycin showed potential in preclinical models (worms, flies, mice) for lifespan extension (20-25%) and improved muscle performance.
- In a human trial, Rapamycin dosed once a week did not outperform placebo in improving muscle performance in older adults aged 65-85.
- Focus on exercise and diet as proven methods to combat aging-related issues like coronary heart disease and obesity.
Supplements & Protocols Mentioned
- Rapamycin dosed once a week during the trial.
Notable Quotes
“With coronary heart disease, that’s essentially a solved problem. With all of the remedies that we’ve got now, and the things that we can prescribe and diet, exercise, sleep, all those good things, it’s essentially a solved problem.”
Bottom Line
While Rapamycin shows promise in preclinical studies, focus on lifestyle interventions like exercise and diet for aging-related health improvements.
Explore supplements mentioned in this video
Explore More
- Siim Land’s Full Protocol — supplements, dosages, and daily routine
- Compare All Protocols — side-by-side protocols
Watch the Full Video
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.
Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.
No spam. Unsubscribe anytime. Powered by Beehiiv.
Related Research
From Our Research Network
Daily longevity researchZone2 Training
Exercise protocolsSleep Science
Sleep optimization
Part of the Evidence-Based Research Network